1. Organisations and groups that collaborated in the overview were the British MRC, Eastern Cooperative Oncology Group, European Organisation for Research and Treatment of Cancer, German Ovarian Cancer Study Group, Gruppo Intergionale Cooperativo Oncologico Ginecologia, Gruppo Oncologico Nord Ovest, Gynecologic Oncology Group, Gynaecological Group Clinical Oncological
2. Estimates of the worldwide frequency of sixteen major cancers in 1980;Parkin, D.M.; Laara, E.; Muir, C.S.;IntJ Cancer,1988
3. Advanced ovarian carcinoma: a prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy;Young, R.C.; Chabner, B.A.; Hubbard, S.P.,1978
4. Phase II study of cisdichlorodiammineplatinuin (II) (NSC 119875). Cancer Treat Rep;Wiltshaw, E.; Kroner, T.,1976
5. A pilot study of cisdichlorodiammineplatinum (II) in combination with Adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously untreated patients;Williams, C.J.; Stevensen, K.; Buchanan, R.;Cancer Treat Rep,1979